Dimyristoyl Lecithin; Perflexane Patent Expiration

Dimyristoyl Lecithin; Perflexane is Used for medical imaging purposes. It was first introduced by Vesselon Spv Llc in its drug Imagent on May 31, 2002.


Dimyristoyl Lecithin; Perflexane Patents

Given below is the list of patents protecting Dimyristoyl Lecithin; Perflexane, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Imagent US5798091 Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement Aug 25, 2015

(Expired)

Vesselon Spv Llc
Imagent US5720938 Systems for the formation of microbubbles Feb 24, 2015

(Expired)

Vesselon Spv Llc
Imagent US5695741 Stable microbubble precursors Dec 09, 2014

(Expired)

Vesselon Spv Llc
Imagent US5639443 Stabilized microbubble compositions Jun 17, 2014

(Expired)

Vesselon Spv Llc
Imagent US5626833 Ultrasound imaging method using microbubbles May 16, 2014

(Expired)

Vesselon Spv Llc
Imagent US5605673 Stabilized microbubble compositions for ultrasound Feb 25, 2014

(Expired)

Vesselon Spv Llc
Imagent US6280704 Ultrasonic imaging system utilizing a long-persistence contrast agent Jul 30, 2013

(Expired)

Vesselon Spv Llc
Imagent US6280705 Kits & systems for ultrasonic imaging Jul 30, 2013

(Expired)

Vesselon Spv Llc
Imagent US6287539 Methods of imaging using osmotically stabilized microbubble preparations Jul 30, 2013

(Expired)

Vesselon Spv Llc



Dimyristoyl Lecithin; Perflexane's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List